Fig. 6From: Calycosin-loaded nanoliposomes as potential nanoplatforms for treatment of diabetic nephropathy through regulation of mitochondrial respiratory functionA ROS, B MDA levels in mitochondria of diabetic rats. Data represent mean ± SEM. of three independent runs. ***P < 0.001 relative to control; &&P < 0.01, &&&P < 0.001 relative to D-treated group; $$P < 0.01 relative to D + C- treated group. Diabetic group (D), diabetic group treated with calycosin (D + C), diabetic group treated with calycosin-loaded nanoliposome (D + CN), diabetic group treated with vitamin E (D + VE)Back to article page